Background: The effect of dietary calcium (Ca) on fecal fat excretion in lactose maldigestion is not known. Objective: To investigate the effect of dairy and non-dairy dietary Ca on fecal fat excretion in lactose digesters and maldigesters during moderate energy restriction. Design: A randomized cross-over trial comparing the effect of 500 mg versus 1500 mg dairy and non-dairy Ca on fecal fat excretion in 34 healthy adults during moderate (À30%) energy restriction induced weight loss for 12 weeks. The participants were classified as lactose digester or maldigester on the basis of breath hydrogen test. Measurements: Anthropometric parameters and body composition, resting energy expenditure, energy and nutrient intake, fecal fat, physical activity, blood pressure, blood and urine sampling for pertinent measurements. Results: Fecal fat loss expressed as percent of fat intake was significantly higher with 1500 mg (high Ca) as compared with 500 mg (low Ca) Ca intake per day (mean: 3.0%; 95% CI: 2.3 to 3.7%; Po0.001) independent of Ca source and lactose digestion status. Conclusions: During a moderate energy restriction induced weight loss, a high-Ca diet causes an increase in fecal fat excretion independent of Ca source. Ca intake related fecal fat loss is also independent of the ability to digest lactose and it is not diminished over time (US Clinical Trial Registration: Clinicaltrials.gov NCT00808275) 
Introduction
There is an ongoing controversy over the role of calcium (Ca) intake on body-energy regulation. Low levels of dietary Ca and dairy products have been identified as potential contributing factor to obesity, and have also been linked to increased risk of hypertension and insulin resistance. [1] [2] [3] Despite supportive epidemiological reports, 2,4-7 interventional and mechanistic studies, [8] [9] [10] [11] [12] the suggested antiobesity effect of dairy and non-dairy Ca supplementation remains far from proven as not all investigations have confirmed these findings. Several studies indicate that Ca supplementation or dairy products may have no effect, [13] [14] [15] [16] [17] [18] [19] or even an adverse effect, 20 on body weight. Further, recent reviews and meta-analyses 18, 21 of randomized controlled trials with or without concomitant energy restriction indicate that neither Ca supplementation nor dairy products reliably facilitate weight loss. When found, such a relationship relates to decreased rate of weight 22 or fat gain, rather than weight or fat loss. Two recent trials 23, 24 have reported over two-fold increase in fecal fat loss with increase in dietary Ca intake for 7 days. The authors concluded that their observation might contribute to an explanation for why high-Ca diet might be inversely related to body weight. However, the long-term effects of Ca supplementation on fecal fat excretion are unknown. Moreover, there is no clear evidence that dairyderived Ca would be more effective in causing fecal energy loss than non-dairy Ca. Lactose maldigestion has been linked to low dairy Ca intake and osteoporosis, 25 although a preponderance of evidence suggests that lactose maldigestion should not limit Ca intake since most of the maldigesters can tolerate several servings of dairy foods daily. 26 However, the effect of lactose maldigestion on fecal fat loss secondary to dairy and non-dairy Ca supplementation has not been systematically studied.
The goal of the present study was to determine the effect of dietary Ca on fecal fat loss. We examined the association between lactose maldigestion, dietary Ca level and source, weight loss induced by energy restriction, and fecal fat loss for 12 weeks. We tested the hypothesis that dietary dairy and non-dairy Ca affects energy balance by increasing fecal loss of fat. We also examined a possibility that fecal fat excretion might be different in lactose maldigesters than in lactose digesters.
Materials and methods

Participant selection
We studied healthy males (10) and females (24) , aged 21-50 years with body mass index 29-35 kg m
À2
. The volunteers were recruited using flyers, mass e-mails, and word of mouth. Potential participants with history of medical illness, including diabetes, hypertension, renal, liver or heart disease, pregnant or lactating mothers, those taking medications or dietary supplements that affect body weight, lipid-lowering medications or thyroid hormone substitution, or engaged regularly in heavy or vigorous physical activities were excluded from the study. Volunteers with known or suspected drug or alcohol abuse and tobacco users were also not recruited.
We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research. The trial was conducted at the Clinical Research Center (CRC) at Vanderbilt University, Nashville, Tennessee, USA and was approved by the Institutional Review Board of Vanderbilt University and followed the ethical principles of the Helsinki-II Declaration. Each participant provided written consent before the study.
Study design
Based on breath hydrogen test, lactose digesters and maldigesters were randomly assigned in a single-masked manner to one of two energy restriction diets: (1) dairy Ca in the form of dairy products and (2) non-dairy Ca in the form of food products excluding dairy. Each diet had two levels of dietary Ca: 500 mg (low Ca) and 1500 mg (high Ca). Nondairy, high-Ca diet was supplemented with Ca citrate (1000 mg of Ca). A sequence of the two levels of dietary Ca, either low-high Ca (500-1500 mg) or high-low Ca (1500-500 mg) was randomly assigned to each participant for 12 weeks (6 weeks each diet) in a cross-over design. Adherence to the protocol was monitored by collecting selfreports of uneaten foods. Urinary nitrogen, sodium and potassium were measured weekly in 24-h urine samples, as biomarkers of intake.
Diets
Study participants received individualized energy-and nutrient-controlled diet for the whole study period provided by the CRC metabolic kitchen for consumption at home. The food items in these diets were similar to those regularly used in the US and were adjusted to individual preferences. Energy needs were calculated as sum of resting energy expenditure (REE) measured using metabolic cart (CPX Optima; MedGraphics, St Paul, MN, USA), EE of physical activity measured using accelerometer (RT3; StayHealthy, Monrovia, CA, USA) for one week before the study and thermic effect of food estimated as 10% of REE. The individualized diet (10-day diet cycle) provided in daily portions contained approximately 70% (±210 kJ) of daily energy requirements, 52-54% of energy from carbohydrates, 26-29% of energy from fat, 17-21% of energy from protein and 17-21 g of fiber. To assure sufficient micronutrient content of the diet, participants received a multivitamin supplement daily (Nature Made, Mission Hills, CA, USA). After 6 weeks energy content of the diet was lowered (420-840 kJ day
À1
) to reflect changes in body weight. No restrictions were imposed on the amounts of energy-free foods such as water, coffee (without sugar or milk), diet soft drinks, salt and pepper. All food items were marked (breakfast, lunch, dinner and snack) and foods for each day were packed in thermo-insulated bags. The dinner meals were preprepared and only needed to be heated. Each participant received a written, daily list of foods at every diet pick-up (four times a week). Any uneaten food and any additional food eaten by the participants were reported daily on sheets collected at food pick-up. The study dietitian met with each participant weekly to discuss the diet, resolve any barriers and concerns related to food or specimen collection, and encourage compliance. Each participant was allowed 1 or 2 days (that is, birthday, holiday) on which additional foods could be eaten. Intake data were analyzed for energy and nutrient content using the NDS-R database (Nutrition Data System, St Paul, MN, USA).
Lactose digestion
Lactose digestion was assessed by measuring alveolar breath hydrogen exhalation at 30-min intervals for 3 h following a lactose oral challenge, as described previously. 26 Participants were classified as lactase deficient (lactose maldigesters) on the basis of a rise in breath hydrogen concentration of greater than 0.90 mmol l À1 (420 p.p.m.) after ingestion of 25 g of lactose in 250 ml of water.
Body composition and anthropometric data
The National Health and Nutrition Examination Survey (NHANES) protocols 27 were followed for all anthropometrical measurements. Body weight was measured at baseline and thrice weekly to the nearest 0.1 kg using a calibrated beam platform scale (Detecto-Medic; Detecto Scales Inc.,
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Northbrook, IL, USA). Height was measured at baseline to the nearest 0.5 cm using a calibrated, wall-mounted stadiometer (Perspective Enterprises, Portage, MI, USA). Waist circumference was measured in standing position to the nearest 0.1 cm at the mid-axillary high point of the iliac crest at minimal respiration at baseline and after 4, 8, and 12 weeks of energy restriction diet. The averages of the two readings were used for analysis. All measurements were performed by the same investigator. Body composition was determined by dual energy X-ray absorptiometry (DXA) at baseline and after 12 weeks using narrow fan-beam technology (GE Lunar Prodigy, Madison, WI, USA). Fat mass and fatfree mass were determined, and fat-free mass was further divided into lean body mass and bone mineral content. For quality assurance and equilibration, a calibration block was scanned each morning. A spine phantom was scanned on a weekly basis; the coefficient of variation (%) was 0.7%. Totalbody water was measured using bioelectrical impedance (Quantum-II Desktop; RJL Systems, Clinton Township, MI, USA). The measurement was performed promptly after DXA measurement by the same investigator. Data were entered into the software program provided by the manufacturer (Cypress; RLJ Systems, Clinton Township, MI, USA).
Resting EE
Resting EE was measured at baseline and after 12 weeks, and was defined as the average EE during a 30-min period of lying in a supine position after a 30-min rest following an overnight fast (410 h), using metabolic cart (CPX Ultima; MedGraphics, St Paul, MN, USA).
Physical activity
Daily physical activity was assessed using an RT3 accelerometer (StayHealthy; Monrovia, CA, US, USA). The participants were instructed to maintain their habitual physical activity throughout the study. They wore the activity monitor on their right hip while awake for the duration of the study. The results were downloaded weekly and total and physical activity EE were calculated using energy calculated from the amount of movement measured by the monitor and REE measured at baseline. Physical activity levels were calculated by dividing total EE by REE for each monitored day.
Blood pressure Blood pressure was measured three times a week in the reclining position after a 10-min rest with an automatically inflating cuff (Dynamap; General Electric, Milwaukee, WI, USA).
Urine analyses
The complete 24-h urine samples were collected weekly. Urine volume and density were measured and a sample of 10 ml was frozen at À70 1C until further analysis in the CRC Core laboratory. Urinary Ca, sodium and potassium were measured using Vitros 250 Analyzer (Ortho-clinical Diagnostics, Rochester, NY, USA). Urinary nitrogen content was measured using a nitrogen analyzer (Antek instrument nitrogen system 9000NS; Antek Instruments Inc., Houston, TX, USA). The nitrogen excretion of the urine was used as a biological marker for protein intake by multiplying the content of nitrogen in the urine by the factor 7.72. 28 The sodium content of the urine was used as a biological marker of sodium intake 29 and potassium content in the urine divided by 0.77 was used as a biological marker of potassium intake. 30 
Blood analyses
Venous blood samples were drawn in the morning after an overnight fast at baseline, at 6 weeks and on the last day of the study (12 weeks). A basal metabolic panel including glucose and routine hematological indices (hemoglobin concentration, hematocrit, red and white blood cells count) was analyzed in the Vanderbilt University Hospital Laboratory using standard methodologies. Blood for determination of insulin, leptin, parathyroid hormone, and vitamin D was centrifuged at 2800 g for 15 min at 4 1C. Serum was extracted and the samples were stored at À70 1C until later analyses at the Vanderbilt Diabetes Research Center Hormone Assays Laboratory.
Fecal fat analyses
All feces excreted during one weekend day (24 h) were collected in plastic containers during all 12 weeks of the study. In addition, the subjects completed a questionnaire on daily defecation frequency during the whole study. The fecal samples were weighed and frozen at À20 1C until sent to the analytical laboratory (Arup Laboratories, Salt Lake City, UT, USA) for fecal fat analysis using gravimetric method.
Statistical analysis
Data are presented as means, standard deviations (s.d.) or ranges. We considered the weekly measurements of fecal fat excretion calculated as percent of fat intake as well as their average over 12 weeks as the major outcomes. Since fecal fat excretion was consistent over 6 weeks within each Ca intake level and diet source (dairy or non-dairy), the average of fecal fat excretion over 6 weeks was used as the primary outcome in the final analysis. Random-effects models were used with generalized least-square estimators and Huber/White/sandwich estimator of variance. As main effects in the model, Ca intake level (500 and 1500 mg day À1 ), diet source (dairy and non-dairy), lactose digestion status (digester and maldigester) and gender (male and female) were included. Differences between means for body fat and weight loss, urinary Calcium and fecal fat excretion MS Buchowski et al biomarkers, EE and physical activity were analyzed by paired t-test. All tests were two-tailed and a P-value less than 0.05 was considered significant. Analyses were performed using STATA 9.2 (StataCorp, College Station, TX, USA) and R (www.r-project.org).
Results
A total of 51 volunteers were recruited for the study; 40 were randomized and 34 completed the study (19 Caucasians, 11 African Americans and 4 declaring other ethnicities). One participant was dropped due to noncompliance and five withdrew between week 1 and 8. Baseline and end-of-thestudy characteristics of participants who completed the study are shown in Table 1 . There was no difference in initial weight and body composition between lactose maldigesters and digesters, and between dairy and non-dairy diets (all P40.05).
Dietary intake and compliance with the study diets The participants had an average energy intake of 7.5±1.5 MJ ( Table 2 ). The average intake of energy from carbohydrates, fat and protein was 54.5 ± 3.0, 28.9 ± 2.6 and 18.4 ± 1.85%, respectively. There were no differences between macronutrient and fiber content between the diets (dairy versus non-dairy). Average amount of Ca in low-Ca and high-Ca diets was 503 ± 73 and 1491 ± 131 mg day À1 , respectively, and the level was not different between dairy and non-dairy diets. There were no significant differences between the intake of protein, sodium and potassium, and their respective biological markers in weekly urine collections (Table 3 ). The ratio of nitrogen in urine and corresponding protein intake were not significantly different between the dairy and non-dairy diets (1.13±0.41 and 1.01±0.14; P ¼ 0.105). There were also no differences between the ratios of reported intake and excretion between dairy and non-dairy diets for sodium (0.96 ± 0.20 and 0.95 ± 0.19; P ¼ 0.917) and potassium (1.15±0.23 and 1.12±0.16; P ¼ 0.684).
Fecal fat excretion
The average fecal fat loss (Table 4) over 6 weeks was significantly higher with high-Ca diet than that with low-Ca diet after adjusting for gender, lactose digestion status and dairy or non-dairy diet source (mean: 3.0%; 95% confidence interval (CI): 2.3-3.7%; Po0.001). Fecal fat loss increased correspondingly with cross-over to high-Ca diet and vice versa (Figure 1 ). It was also significantly higher in females than in males after adjusting for Ca intake level, lactose digestion status and dairy or non-dairy diet source (mean: 2.0%; 95% CI: 1.2-2.9%; Po0.001). There was no significant Cross-over design with high-Ca diet (1500 mg day À1 ) and low-Ca diet (500 mg day
À1
) administered in random order for 6 weeks (total 12 weeks). The nutrient content was estimated using NDS-R dietary assessment software (NDS, St Paul, MN, USA).
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MS Buchowski et al difference in fecal fat loss between lactose digesters and maldigesters ( Figure 2 ) after adjusting for gender, Ca intake level and dairy or non-dairy diet source (mean: 0.2%; 95% CI: 0.5-1.0%; P ¼ 0.544). There was a significant positive correlation between Ca intake and fecal fat excretion in dairy (r ¼ 0.460) and non-dairy (r ¼ 0.555) diets and in lactose digesters (r ¼ 0.562) and maldigesters (r ¼ 0.463, all P40.05).
Although not statistically significant, the average fecal fat loss over 12 weeks was higher in the non-dairy than that in the dairy diet group (Figure 1 ) after adjusting for Ca intake level, lactose digestion status and gender (mean: 0.5%; 95% CI: 0.2-1.2%; P ¼ 0.150). In females, the average fecal fat loss over 6 weeks tended to be higher with the non-dairy than that with the dairy diet after adjusting for Ca intake level and lactose digestion status (mean: 0.8%; 95% CI: À0.1-1.6%; P ¼ 0.067).
Urinary Ca excretion
Urinary Ca excretion ( 28 and potassium in urine divided by 0.77 (Johansson et al., 1992 ).
c
P-values represent comparisons of the reported intakes of protein, sodium and potassium with the respective urinary excretion analyzed using the paired t-test. Average daily fat excretion in 24-h stool samples (12 weekly collections). % of fat intake was calculated as a % ratio of weekly fat excretion to average weekly fat intake. Calcium and fecal fat excretion MS Buchowski et al P ¼ 0.014). The differences in Ca excretion were not different between dairy versus non-dairy diets, and for digesters versus maldigesters (all P40.05).
Body weight and body composition
After following an energy-controlled diet for 12 weeks (Table 1) , there were no significant differences in weight loss between dairy and non-dairy diets (8.5 ± 2.7 and 7.2±2.8 kg; P ¼ 0.116). However, there were significant differences in weight changes in lactose digesters versus maldigesters (9.2 ± 2.2 and 6.6 ± 2.4; P ¼ 0.003). There was also significant differences between first and second 6-week study periods (5.6±1.8 and 2.8±1.7 kg; P ¼ 0.001).
The differences between dairy and non-dairy diets were not significant during the first 6-week (5.7 ± 1.9 and 5.5 ± 1.7 kg) or second 6-week (2.9 ± 1.9 and 2.9 ± 1.8 kg) periods. There were also no significant differences in body fat changes across groups: dairy versus non-dairy (5.4 ± 1.5 and 4.1 ± 1.5; P ¼ 0.393) or lactose digesters versus maldigesters (5.5 ± 1.3 versus 4.8±1.7; P ¼ 0.206). There were also no differences in the amount of total body water between the groups.
Resting EE and physical activity There was a difference in REE between the baseline and the end of the study (7.31 ± 1.31 versus 6.74 ± 1.32 MJ), which became insignificant when REE was adjusted for fat-free mass and fat mass (data not shown). There were not REE differences between digesters and maldigesters ( Table 6 ).
The differences in the amount of physical activity measured using RT3 accelerometers during the entire study were also not significant. Participants did not change physical activity level during the study (Table 6 ).
Blood pressure and blood parameters Diet had no significant effect on either systolic or diastolic blood pressure (Table 7) . Basic hematological parameters were not different between the groups (data is not shown). Diet did not have an effect on the serum concentrations of insulin and vitamin D. Leptin levels decreased significantly after 12 weeks with the study diet independent of diet and lactose digestion status (40.6±20.3 versus 27.3 ± 16.7 ng ml
À1
; P ¼ 0.001, paired t-test). Calcium and fecal fat excretion MS Buchowski et al
Discussion
The novelty of the present study is that we investigated the random effect of dairy and non-dairy Ca intake on fecal fat excretion in lactose digesters and maldigesters during energy restriction-induced weight loss. The major finding is that high-Ca diet causes an increase in fecal fat loss independent of Ca source (dairy and non-dairy) and the ability to digest lactose. The effect of dietary Ca on fecal fat loss was not diminished over 12 weeks. Fecal fat loss increased correspondingly with cross-over to high-Ca diet and vice versa as illustrated in Figure 1 . Compared with low-Ca diet, high-Ca diet increased fecal fat excretion by 1.8 g day À1 , or about 3% of daily fat intake (6.7±1.9 versus 4.7±1.8 g day
À1
). This increase in fat excretion could produce 63-125 kJ (15-30 kcal) per day of fecal energy loss, which could cause approximately 0.4-0.7 kg body fat loss over the 1-year period. This difference might be clinically relevant to long-term body weight regulation.
The results of this 12-week investigation of effect of high Ca diet on fecal fat excretion are in line with prior, shortterm (1 to 2 weeks) human trials. 24, [31] [32] [33] ) for a week. Very recently Bendsen et al. 23 and Jacobsen et al. 24 have reported an increase in fecal fat excretion of over 2-and 2.5-fold by increasing daily Ca intake to 2300 and 1800 mg from 700 and 500 mg, respectively. In a 7-day trial with dairy and nondairy Ca supplementations, Boon et al. 34 also observed a non-significant trend toward higher fat excretion with the high-Ca diet, noting a 56% higher fecal fat excretion with a 2500 versus 400-mg Ca diet. Fecal fat loss in this study (8.2 g day À1 ) was comparable or lower than the fat loss reported in other studies. The differences may be largely explained by different Ca and protein contents of the diets used for the studies. It is known that a high protein intake increases Ca bioavailability, leaving less Ca available for binding with fat in the intestine. 35, 36 For example, Jacobsen et al. 24 have noted modulation of the effect of high-Ca intake on fecal fat excretion by protein content of the energy intake. They have reported a fecal fat loss of 14.2 versus 6.0 and 5.9 g day
with high Ca (1800 mg)-normal protein (15% of daily energy intake), low Ca (500 mg)-normal protein (15% of daily energy intake), and high Ca (1800 mg)-high protein (23% of daily energy intake) diets, respectively. The authors found no difference in fecal fat excretion between the low Canormal protein and the high Ca -high protein diets. We tested the effect of 1500 and 500 mg Ca diets with protein content of 17-21% of daily energy intake. We also observed that fecal fat loss was comparatively less stable in the first 6-week than in the second 6-week period (Figure 1 ). We do not have a definite explanation for that. Perhaps it might be related to greater weight loss in the first as compared with the last 6 weeks of energy restriction across all the variables studied. We cannot, however, compare our results to other studies since to the best of our knowledge no trial was reported with similar length (6 or 12 weeks) of controlled Ca intake and fecal fat excretion measurement.
Our results further signify that fecal fat loss with a high-Ca diet is not diminished over time, and this effect is not different for lactose digesters and maldigesters, and with dairy and non-dairy Ca.
In our study, we did not observe any significant differential effect of dairy Ca on fecal fat loss. However, Lorenzen et al. 37 in a randomized, crossover study with four isocaloric meals with differing amount or source of Ca reported a decrease in fat absorption with dairy Ca supplementation. It is not clear why Ca from dairy products, but not Ca from supplement, was found to inhibit fat absorption. The authors are of the opinion that dairy Ca is largely present as insoluble Ca phosphate, which binds bile acids and impairs micelle formation, leading to increased fecal fat loss. However, Bendsen et al. 23 have recently shown that increasing the daily intake of Ca from low-fat dairy products by 1600 mg for 7 days doubled the total fecal fat excretion (11.5±1.4 from 5.4±0.5 g), but did not affect the excretion of bile acids. Their results suggest that fecal fat loss is not caused by binding of bile acids, but rather it may be due to Ca soap formation in the intestine. Calcium and fecal fat excretion MS Buchowski et al
Our results indicate that lactose maldigestion has no significant effect on fecal fat loss or urinary Ca excretion associated with dietary Ca. Approximately 70% of the world's population loses the ability to digest large amounts of lactose after weaning, and this lactase non-persistence is inherited as an autosomal recessive trait. 38 Several investigators have reported increased prevalence of osteoporosis among symptomatic lactose maldigesters. [39] [40] [41] Our findings are in line with the current understanding that inadequate Ca intake rather than lactose maldigestion per se is related to the consequences of Ca deficiency such as osteoporosis. 42, 43 We noted that mean weight loss, but not fat loss, tend to be higher for lactose digesters as compared for lactose maldigesters. However, this study was not specifically designed to examine the effect of Ca on weight loss and does not have the power to support any such conclusions. All the participants were on isocaloric restriction and we found no significant differences in weight changes with the source of Ca after 12 weeks of energy restriction. Prior studies have reported conflicting effects of dairy or non-dairy Ca supplementation on weight loss, from no effect [13] [14] [15] [16] [17] [18] [19] to significant effect. [8] [9] [10] [11] [12] 44 Our study must be interpreted within the context of our experimental design. The sample size was relatively small considering dietary Ca intake level, dairy or non-dairy diet source, lactose digestion status and gender as variables. However, it was a randomized, controlled, cross-over trial with similar numbers of lactose digesters and maldigesters. Second, we did not measure fecal Ca but used urinary Ca as a marker of Ca intake. We also did not quantify fecal fat complexes (soaps) as a surrogate to saponification. Rather, we relied on the comparison of fecal fat excretion with low and high dietary Ca intake. Third, 24-h stool samples were collected once per week. However, given constant content and reported intake of energy, macronutrients and micronutrients, including Ca of daily diets prepared by the metabolic kitchen, it was reasonable to assume that stool fat content was also not different. Fourth, the cross-over design was used only for dietary Ca level. Thus, the reason we could not detect the significant difference between non-dairy and dairy diet source could be due to large variability across subjects, constant amount of dietary Ca in respective diets and possible gender differences. Our results for the effect of diet type or lactose digestion status would require further study.
In summary, we found that during moderate (À30%) energy restriction-induced weight loss, a high-Ca diet causes increases in fecal fat excretion independent of the Ca source. The new findings are that Ca intake-related fecal fat loss is also independent of the ability to digest lactose and is not diminished over time.
